Zobrazeno 1 - 9
of 9
pro vyhledávání: ''
Publikováno v:
Renal Replacement Therapy. 2(1)
Adverse reactions, such as anaphylactoid shock, have been reported to occur frequently with the use of polysulfone (PSf) membrane dialyzers. Polyvinylpyrrolidone (PVP) elution from the membrane may be a key factor in these reactions. In this paper, w
Publikováno v:
Renal Replacement Therapy. 2(1)
Prolonged intermittent renal replacement therapy (PIRRT) is a growing option to treat acute kidney injury in critically ill patients, but absent pharmacokinetic data challenge optimal drug dosing. Inappropriate antibiotic dosing can cause widespread
Publikováno v:
Renal Replacement Therapy. 2(1)
Erythropoietin deficiency is the major cause of anemia in hemodialysis patients. Although continuous erythropoietin receptor activator (CERA) has a long half-life and once-monthly administration is recommended, the optimal interval to achieve the gre
Publikováno v:
Renal Replacement Therapy. 2(1)
Lanthanum carbonate (LC), an effective phosphate (P) binder, is widely used to manage hyperphosphatemia in hemodialysis patients. However, the long-term safety of LC treatment in clinical practice has not been completely established. In an observatio
Publikováno v:
Renal Replacement Therapy. 2(1)
Kocuria kristinae is an aerobic Gram-positive coccus that is considered ubiquitous and non-pathogenic in healthy individuals. Furthermore, only 27 reports have described cases of critical infections with this microorganism, which is notoriously diffi
Autor:
Masahiro Inagaki, Mayumi Tsuji, Hiroki Suzuki, Tatsunori Oguchi, Hitomi Hasegawa, Yoshikazu Goto, Michiyasu Inoue, Masatomo Mihara, Kazumasa Nishida, Hiromichi Gotoh, Katsuji Oguchi, Tatsuo Shimizu, Yuya Nakamura, Isao Ohsawa
Publikováno v:
Renal Replacement Therapy. 2(1)
Linagliptin, the only bile-excreted dipeptidyl peptidase-4 (DPP-4) inhibitor, is a therapeutic drug for patients with diabetes receiving hemodialysis, for whom inflammation is a prognosis-related factor, because of its potential anti-inflammatory eff
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-10 (2017)
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Most cases of aHUS are caused by uncontrolled complement activation due to
Autor:
Kiichiro Fujisaki, Kazuhiko Tsuruya
Publikováno v:
Renal Replacement Therapy. 2(1)
Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease and also increases the incidence of cerebrovascular disease. Prevention and management of cerebrovascular disease in patients with CKD, especially end-stage kidney
Autor:
Shinichiro Tsuchiya, Hideki Kawanishi, Naoko Takahashi, Takao Masaki, Junko Kumagai, Misaki Moriishi, Taku Yoshizawa
Publikováno v:
Renal Replacement Therapy. 2(1)
Pruritus in hemodialysis patients is a serious complication that lowers quality of life and adversely affects survival. Hemodialysis-associated pruritus has multiple causes and treatments; however, no effective treatment has been established and many